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Purpose: Dengue fever occurs in many popular tourist destinations and 
is increasingly imported by returning travelers in Korea. Since Korea is 
not an endemic country for dengue fever, pediatricians do not usually 
suspect dengue fever in febrile children even with typical presentation 
and exposure history. This study was performed to describe the 
international travel experiences and dengue fever in Korean children.
Methods: Travel histories were collected based on questionnaires 
completed by all patients’ guardians who visited the pediatric 
infectious diseases clinic at Samsung Medical Center from January 
2008 to December 2008. For patients who were suspected of dengue 
fever, a serological test was performed. 
Results: Five hundred and seventeen children visited the pediatric 
infectious diseases clinic for the first time during this period. About 
30% of patients who responded to the questionnaire (101/339) had 
experienced international travel within the last 2 years. Four patients 
were diagnosed with dengue fever by serological test. 
Conclusion: Increasing numbers of Korean children visit dengue 
endemic areas and they may return home with dengue fever. Dengue 
fever should be suspected in patients who have a travel history to 
endemic areas. 
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Introduction
Dengue is an acute influenza-like disease caused by mosquito-
borne arboviruses of the family Flaviviridae, with four different 
serotypes: DEN-1, DEN-2, DEN-3 and DEN-4
1, 2). Dengue 
viruses are maintained in cycles of human-mosquito-human 
transmission, the major vector is Aedes aegypti, and recently 
Aedes albopictus is found as a less-efficient but more adaptable 
vector
1). Dengue is found in tropical and sub-tropical regions 
around the world, predominantly in urban and semi-urban 
areas. The incidence of dengue has grown dramatically around 
the world in recent decades. About 2.5 billion people - 40% of 
the world’s population - are now at risk for dengue. The World 
Health Organization (WHO) currently estimates that there may 
be 50 million to 100 million dengue infections world wide every 
year, with 500,000 hospitalizations and 22,000 deaths, mostly in 
children
3). Dengue is now endemic in more than 100 countries 
in Africa, the Americas, the Eastern Mediterranean, South-east 
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Asia and the Western Pacific region. The South-east Asia and 
Western Pacific regions are the most seriously affected with lethal 
complications such as dengue hemorrhagic fever
3). In Korea, 22 
cases of pediatric dengue fever from 2001 to 2008 were reported 
according to the data collected by the Korea Centers for Disease 
Control and Prevention (KCDC)
4). All cases were imported 
dengue fever
5).
Many countries where dengue is endemic are popular tourist 
destinations and the disease is an increasingly important problem 
encountered by international travelers. The importance of dengue 
to pediatric infectious diseases practice has been increasing
1, 
6-8). This study was performed to estimate international travel 
experiences of Korean children and to report clinical features of 
dengue fever. 
Methods
Data was collected from all patients who visited the pediatric 
infectious diseases clinic at Samsung Medical Center from January 
2008 to December 2008. All new patients were asked through a 
questionnaire about their illness and history which included travel 
and environmental exposure history. Four patients who returned 
from international travel were suspected of dengue fever. Enzyme-
liked immunosorbent assay detecting serum IgM and IgG (Dengue 
Duo IgM and IgG capture ELISA) was performed according 
to the manufacturer’s protocol (Inverness Medical Innovations 
Australia Pty Ltd, Sinnamon Park, Queensland, Australia) at 
the Korea Centers for Disease Control and Prevention (KCDC). 
Medical records and questionnaires were reviewed.  
Results
Five hundred and seventeen patients visited the pediatric 
infectious diseases clinic at Samsung Medical Center from January 
2008 to December 2008. Three hundred and thirty nine patients 
(65.6%, 339/517) responded to the questionnaire. One hundred 
and one patients (29.8%, 101/339) had experiences of international 
travel within 2 years and 26 patients (25.7%, 26/101) had visited 
more than two countries. The popular destinations were the 
USA (n=32, 31.7%), China (n=23, 22.8%), Japan (n=21, 20.8%), 
Singapore (n=10, 9.9%), Thailand (n=8, 7.9%), the Philippines (n=7, 
6.9%), and Indonesia (n=7, 6.9%) in order (Fig. 1). 
There were 7 patients who had a fever and international 
travel history within 2 weeks at the time of presentation. Four 
patients were suspected of dengue fever based on their symptoms, 
laboratory values and travel history to endemic areas. 
Dengue serological tests were requested and the results were 
positive in all 4 tested patients. Table 1 shows the clinical and 
laboratory features of the patients diagnosed with dengue fever. 
There were one female and three male patients. The range of 
ages was from 8 to 19 years. All four patients had visited the 
Philippines. Patient 1 had a past medical history of osteosarcoma 
which had been completely cured with chemotherapy and a 
limb salvage operation in 2003. She was presented with a fever 
and maculopapular skin rash after 3 days of her return. She was 
initially seen by a hematology-oncology team due to her previous 
cancer history, fear of cancer recurrence and cytopenia at the 
time of presentation. However, an infectious diseases team was 
consulted on this patient and observation with conservative 
management was recommended since dengue fever was suspected. 
Patient 2 developed a fever and pin-pointed hemorrhagic rash over 
his whole body after 5 days of his return. Patient 3 and 4 were 
brothers who complained of fever, rash and vomiting since the day 
they returned. The symptoms lasted for one week. Patient 3 and 
4 had also visited a hematology-oncology clinic first due to their 
known history of cytopenia diagnosed at an out-side hospital. They 
were referred to an infectious diseases clinic for evaluation. All 
four patients showed mild to moderate leukopenia (median 1,360/
mm
3) and thrombocytopenia (median 100,500/mm
3) and mildly 
increased serum aminotransferases (median AST/ALT 58.5/61 
U/L). However, none of the patients had signs of a capillary leak; 
elevated hematocrit (20% or more over base line), low albumin, 
pleural or other effusion. Only one patient was hospitalized (Patient 
1) and the other three patients were treated as outpatients. They 
recovered from the illness with supportive care without significant 
complications. 
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Fig. 1. Popular international destinations of Korean children. The popular 
destinations were the USA (n=32, 31.7%), China (n=23, 22.8%), Japan (n=21, 
20.8%), Singapore (n=10, 9.9%), Thailand (n=8, 7.9%), the Philippines (n=7, 
6.9%), and Indonesia (n=7, 6.9%). Korean J Pediatr 2010;53(6):701-704 • DOI: 10.3345/kjp.2010.53.6.701    703
Discussion
For the present, there is no report of dengue occurring in Korea
5, 
9). Six cases of imported dengue were first reported in 2001
5). As 
increasing numbers of international travelers visit dengue endemic 
areas, the incidence of imported dengue has increased. Choi et al
9) 
reported the characteristics of 17 adult cases with dengue fever by 
collecting domestic literature from Korean bibliographic databases. 
Park et al
10) reported the case of a 15 year-old male with dengue 
fever complicated by rhabdomyolysis. This is the first report that 
prospectively estimated international travel experiences and dengue 
fever in Korean children who visited a pediatric infectious diseases 
clinic at a university hospital. 
Dengue fever is a reportable infectious disease (group 4) in 
Korea. The KCDC reported 169 cases of dengue from 2003 to 
2007
5). The destinations of imported dengue patients were mostly 
Asian countries except in one case where the patient was infected 
in Brazil. The most common destination where Korean travelers 
were infected with dengue was the Philippines (36.7%, 62/169). 
Among 169 cases, 13 cases (7.7%, 13/169) occurred under 20 years 
of age. Of note, we diagnosed 4 pediatric dengue cases in 2008 in 
our clinic.  
The data from the Korea national statistical office showed 
that 13.33 million people accounting for 22.3 percent of the 
total population traveled abroad and 11.3 percent of all primary 
school students had international travel experiences in 2007
11). In 
this study, about one third of children who visited the pediatric 
infectious diseases clinic (29.8%) had international travel 
experience during the 12 months of the survey period from 
January 2008 to December 2008. Although the patients who 
visited our clinic may not represent all Korean children in a general 
population considering the socioeconomic differences among 
cities and provinces, this study still shows that Korean children are 
at risk of acquiring dengue fever from travel abroad and Korean 
pediatricians should be more prepared for such patients. Although 
small in numbers, this study is the first report to describe the 
clinical features of dengue fever in Korean children.
Dengue may present symptoms 3-14 days (usually 4-7 days) after 
exposure to the virus and the infection may range from subclinical 
to fever, retro-orbital headache, arthralgia and sometimes a quite 
florid maculo-papular rash usually within 3-5 days following the 
onset of the fever
3). Patients with dengue fever sometimes may 
have hemorrhagic manifestations. Laboratory findings commonly 
include thrombocytopenia, leukopenia with lymphopenia, mild 
to moderate elevations of hepatic aminotransferases and lactate 
dehydrogenase, and hyponatremia
2). The capillary leak results in 
dengue hemorrhagic fever and in its severe or fatal form dengue 
shock syndrome, which are complications defined by the WHO
6, 
12, 13). Although infection with one serotype confers life-long 
protection against that serotype, reinfection with another serotype 
of dengue virus may predispose a person to the development of 
dengue hemorrhagic fever or dengue shock syndrome which have 
more serious outcomes
2). Therefore those who have suffered from 
dengue fever previously should be more careful when traveling to 
endemic areas. 
The spread of dengue is attributed to expanding geographic 
distribution of the four dengue viruses and their mosquito vectors, 
A. aegypti and A. albopictus
14, 15). Of note, although Korea is 
not a dengue endemic country, the A. albopictus (“Asian tiger 
mosquito”) mosquitoes have been discovered throughout Korea
5, 9). 
These mosquitoes are well adapted to life in urban settings
2). Global 
air travel has allowed introduction and cocirculation of different 
serotypes of the virus in new regions. Consequently, dengue has 
developed into a disease of pandemic proportions
16). Although A. 
Table 1. Characteristics of Patients with Dengue Fever 
Patient 1 Patient 2 Patient 3 Patient 4
Gender
Age (yrs)
Destination
Season
Purpose
Travel duration
Clinical presentation
Sign of capillary leak
Lowest WBC (/mm
3)
Lowest PLT (/mm
3)
Highest ALT/AST (U/L)
Dengue Antibody (IgM)
From initial sx to positive antibody (days)
Female
19
Philippines
Feb. 2008
Volunteer work
6 days
F, R
None
1,420
103,000
47/70
Positive
5 
Male
14
Philippines
Jul-Aug. 2008
Study overseas
2 months
F, R
None
1,210
120,000
27/22
Positive
14 
Male
11
Philippines
Jun-Aug. 2008
Study overseas
3 months
F, R, V
None
1,300
44,000
302/179
Positive
11 
Male
8
Philippines
Jun-Aug. 2008
Study overseas
3 months
F, R, V
None
2,560
98,000
70/52
Positive
11
Abbreviations: F, fever; R, rash; V, vomiting: Sx, symptom704      SH Choi, et al. • Korean children and dengue fever
albopictus is native to tropical and subtropical regions, they are 
successfully adapting to cooler regions and have been expanding 
globally at an alarming rate
6, 17-19). Having vectors capable of 
transmitting dengue in Korea has a very important implication 
on the nation’s dengue surveillance since there is the possibility for 
a domestic dengue case by the Aedes albopictus mosquito in the 
future
5, 18).
Many countries where dengue is endemic are popular tourist 
destinations and the disease is an increasingly serious problem 
encountered by international travelers. Many Korean children visit 
dengue endemic areas, may return home with dengue fever and 
there are no vaccines or drugs against dengue yet. 
Dengue fever is not a familiar disease to Korean pediatricians 
which makes its diagnosis harder. Fever in the returned traveler can 
be a manifestation of a minor, self-limited process or can develop 
into a progressive and life-threatening illness. The clinician’s lack of 
familiarity with the types of infections that the patient may have 
encountered while traveling is often an obstacle for the assessment 
of these patients. A systematic approach to the evaluation of febrile 
patients should include basic information about the geographic 
distribution of infectious diseases in the locations where the person 
has lived and traveled
20, 21).
In conclusion, dengue fever should be suspected in Korean 
children who have a travel history to endemic areas and febrile 
illness. 
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